{"id":485674,"date":"2021-05-03T08:04:08","date_gmt":"2021-05-03T12:04:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/"},"modified":"2021-05-03T08:04:08","modified_gmt":"2021-05-03T12:04:08","slug":"feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/","title":{"rendered":"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">MISSISSAUGA, Ontario, May  03, 2021  (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that for the sixth consecutive year, FeraMAX<sup>\u00ae <\/sup>has been named the #1 recommended iron supplement brand in a national survey of Canadian physicians and pharmacists.<\/p>\n<p align=\"justify\">The 2021 OTC Recommendations Survey was conducted by EnsembleIQ, Research, Insights and Innovation team and the following publications and websites<em>: Pharmacy Practice + Business<\/em>, <em>The Medical Post<\/em>, <em>Profession Sant\u00e9<\/em>, CanadianHealthcareNetwork.ca and ProfessionSant\u00e9.ca. This annual survey was conducted online between October 2020 and January 2021 with Canadian retail pharmacists and physicians. In total, 1,812 surveys were completed by pharmacists (including 647 Qu\u00e9bec pharmacists) and 657 surveys were completed by physicians (including 268 Qu\u00e9bec physicians).<\/p>\n<p align=\"justify\">FeraMAX<sup>\u00ae<\/sup> was named by both pharmacists and physicians surveyed (in both Qu\u00e9bec and all Canada) as the most recommended iron supplement brand to Canadian patients.<\/p>\n<p align=\"justify\">Last year, BioSyent Pharma Inc. launched FeraMAX<sup>\u00ae<\/sup> Pd Therapeutic 150, the first product under a patented formulation made with a homogeneous polysaccharide, Polydextrose, linked to ferric (Fe<sup>3+<\/sup>) elemental iron to form the proprietary Polydextrose Iron Complex (\u201cPDIC\u201d).<\/p>\n<p align=\"justify\">\u201cWe are delighted with the continued vote of confidence by healthcare professionals in FeraMAX<sup>\u00ae<\/sup> as their trusted choice for iron deficient patients,\u201d remarked Mr. Ren\u00e9 Goehrum, President and CEO of BioSyent. \u201cThis recognition is especially meaningful in an environment fraught with the complexities of changed healthcare practices during the COVID-19 pandemic. We express our appreciation to healthcare professionals and patients and we look forward to strengthening our partnership with ongoing innovation and commitment to the overall iron health of Canadian patients.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About FeraMAX<\/strong><br \/>\n        <sup><br \/>\n          <strong>\u00ae<\/strong><br \/>\n        <\/sup>\n      <\/p>\n<p align=\"justify\">FeraMAX<sup>\u00ae<\/sup> Pd Therapeutic 150 is an oral iron supplement indicated for the treatment of iron deficiency anemia. This is a patented formulation and the only Polydextrose Iron Complex (PDIC) in Canada. It offers several benefits compared to conventional iron salt supplements and is well-tolerated.\u00a0\u00a0 FeraMAX<sup>\u00ae<\/sup> is Vegan Certified and provides an iron therapy option for vegans, vegetarians, and patients with other dietary restrictions. FeraMAX<sup>\u00ae<\/sup> Pd Therapeutic 150 is also recognized by the Society of Obstetricians and Gynaecologists of Canada, for demonstrated scientific evidence of safety and efficacy. FeraMAX<sup>\u00ae<\/sup> Powder (Polysaccharide-Iron Complex) is available in a pleasant tasting, dissolvable powder for pediatric patients.<\/p>\n<p align=\"justify\">For more information on FeraMAX<sup>\u00ae<\/sup>, please visit <a href=\"http:\/\/www.feramax.com\" rel=\"nofollow noopener\" target=\"_blank\">www.feramax.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>About BioSyent Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Listed on the TSX Venture Exchange under the trading symbol \u201cRX\u201d, BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative pharmaceutical and other healthcare products that have been successfully developed, are safe and effective, and have a proven track record of improving the lives of patients. BioSyent supports the healthcare professionals that treat these patients by marketing its products through its community, specialty and international business units.<\/p>\n<p align=\"justify\">As of the date of this press release, the Company has 12,706,275 common shares outstanding.<\/p>\n<p align=\"justify\">For a direct market quote for the TSX Venture Exchange and other Company financial information please visit <a href=\"http:\/\/www.tmxmoney.com\/\" rel=\"nofollow noopener\" target=\"_blank\">www.tmxmoney.com<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For further information please contact:<\/strong>\n      <\/p>\n<p align=\"justify\">Mr. Ren\u00e9 C. Goehrum<br \/>President and CEO<br \/>BioSyent Inc.<br \/>E-Mail: <a href=\"mailto:investors@biosyent.com\" rel=\"nofollow noopener\" target=\"_blank\">investors@biosyent.com<\/a><br \/>Phone: 905-206-0013<br \/>Web: <a href=\"http:\/\/www.biosyent.com\" rel=\"nofollow noopener\" target=\"_blank\">www.biosyent.com<\/a><\/p>\n<p align=\"justify\">\n        <i>This press release may contain information or statements that are forward-looking.\u00a0 The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements.\u00a0 Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals.<\/i><br \/>\n        <i>\u00a0<\/i>\n      <\/p>\n<p align=\"left\">\n        <i>Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.<\/i>\n      <\/p>\n<p align=\"justify\">\n        <br \/>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/959a58c5-6e48-409e-a412-627bd23de5b0\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MISSISSAUGA, Ontario, May 03, 2021 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that for the sixth consecutive year, FeraMAX\u00ae has been named the #1 recommended iron supplement brand in a national survey of Canadian physicians and pharmacists. The 2021 OTC Recommendations Survey was conducted by EnsembleIQ, Research, Insights and Innovation team and the following publications and websites: Pharmacy Practice + Business, The Medical Post, Profession Sant\u00e9, CanadianHealthcareNetwork.ca and ProfessionSant\u00e9.ca. This annual survey was conducted online between October 2020 and January 2021 with Canadian retail pharmacists and physicians. In total, 1,812 surveys were completed by pharmacists (including 647 Qu\u00e9bec pharmacists) and 657 surveys were completed by physicians (including 268 Qu\u00e9bec physicians). FeraMAX\u00ae was named by &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-485674","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MISSISSAUGA, Ontario, May 03, 2021 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that for the sixth consecutive year, FeraMAX\u00ae has been named the #1 recommended iron supplement brand in a national survey of Canadian physicians and pharmacists. The 2021 OTC Recommendations Survey was conducted by EnsembleIQ, Research, Insights and Innovation team and the following publications and websites: Pharmacy Practice + Business, The Medical Post, Profession Sant\u00e9, CanadianHealthcareNetwork.ca and ProfessionSant\u00e9.ca. This annual survey was conducted online between October 2020 and January 2021 with Canadian retail pharmacists and physicians. In total, 1,812 surveys were completed by pharmacists (including 647 Qu\u00e9bec pharmacists) and 657 surveys were completed by physicians (including 268 Qu\u00e9bec physicians). FeraMAX\u00ae was named by &hellip; Continue reading &quot;FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-03T12:04:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year\",\"datePublished\":\"2021-05-03T12:04:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/\"},\"wordCount\":613,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/\",\"name\":\"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=\",\"datePublished\":\"2021-05-03T12:04:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/","og_locale":"en_US","og_type":"article","og_title":"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year - Market Newsdesk","og_description":"MISSISSAUGA, Ontario, May 03, 2021 (GLOBE NEWSWIRE) &#8212; BioSyent Inc. (\u201cBioSyent\u201d, TSX Venture: RX) is pleased to announce that for the sixth consecutive year, FeraMAX\u00ae has been named the #1 recommended iron supplement brand in a national survey of Canadian physicians and pharmacists. The 2021 OTC Recommendations Survey was conducted by EnsembleIQ, Research, Insights and Innovation team and the following publications and websites: Pharmacy Practice + Business, The Medical Post, Profession Sant\u00e9, CanadianHealthcareNetwork.ca and ProfessionSant\u00e9.ca. This annual survey was conducted online between October 2020 and January 2021 with Canadian retail pharmacists and physicians. In total, 1,812 surveys were completed by pharmacists (including 647 Qu\u00e9bec pharmacists) and 657 surveys were completed by physicians (including 268 Qu\u00e9bec physicians). FeraMAX\u00ae was named by &hellip; Continue reading \"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-03T12:04:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year","datePublished":"2021-05-03T12:04:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/"},"wordCount":613,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/","name":"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=","datePublished":"2021-05-03T12:04:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNzQwMSM0MTQ5MjA0IzIwODk2Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/feramax-named-1-recommended-iron-supplement-by-national-pharmacists-and-physicians-for-sixth-consecutive-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"FeraMAX\u00ae Named #1 Recommended Iron Supplement by National Pharmacists and Physicians for Sixth Consecutive Year"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/485674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=485674"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/485674\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=485674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=485674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=485674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}